Cambridge Laboratories (Ireland) Limited – Trademark Portfolio

Entity Type: 16

Cambridge Laboratories (Ireland) Limited holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. Currently, 1 trademark is registered. Notable registered marks include XENAZINE. The owner is based in DUBLIN.

THE SWEEPSTAKES, BALLSBRIDGE

ALEXANDER HOUSE

DUBLIN 4 , IE

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ZENAZINE
ZENAZINE
Abandoned 2008
ZENAZINE
ZENAZINE
Abandoned 2004
NITOMAN
NITOMAN
Abandoned 2003
ZENILONE
ZENILONE
Cancelled 2002
XENAZINE
XENAZINE
Registered 2000

Trademark Classifications

Cambridge Laboratories (Ireland) Limited's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Cambridge Laboratories (Ireland) Limited have?

Cambridge Laboratories (Ireland) Limited has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 2 cancelled.

What trademark classes does Cambridge Laboratories (Ireland) Limited file in?

Cambridge Laboratories (Ireland) Limited files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Cambridge Laboratories (Ireland) Limited's most well-known trademarks?

Cambridge Laboratories (Ireland) Limited's registered trademark portfolio includes well-known marks such as XENAZINE. These are among 1 currently registered trademark in the portfolio.

What is Cambridge Laboratories (Ireland) Limited's trademark registration success rate?

Cambridge Laboratories (Ireland) Limited has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.